Navigation Links
Update: SpineMark Expands Management Team to Build Spine Care Network

SAN DIEGO, Oct. 19 /PRNewswire/ -- This press release updates a previous press release issued Monday, October 15, by SpineMark Corporation over PR Newswire.

SpineMark Corp., a medical management company that is building a network of Spine Centers of Excellence to support and connect physicians, facilities and medical device companies in order to provide patients the best spine care, announced today the appointments of Alan Donald, M.S., M.B.A., R.A.C. as president of SpineMark CRO Management Inc. and Alan Iftiniuk as interim chief operating officer of SpineMark Corporation.

"Our goal at SpineMark is to bring together physicians, hospitals and device companies to deliver the most advanced spine care to patients," said Marcy Rogers, president and CEO of SpineMark Corp. "These individuals bring more than 50 years of combined experience in healthcare business development and management and will help us integrate spine care clinical research and maximize financial and operational potential for physicians and institutions."

Mr. Donald combines medical research, business development and international regulatory sciences to drive products from the bench to commercialization. Over the past 25 years, he has advised more than 200 companies across four continents on the approval of biologics, drugs, diagnostics and medical devices. In his role as president of SpineMark CRO Management, Mr. Donald will work with medical device companies and physicians within the SpineMark network to establish clinical trial programs that offer patients the most advanced spine care.

"SpineMark has created a unique network of physicians, research institutions and medical device companies that are working together to provide the future of spine care," said Mr. Donald. "This exclusive network advances spine care by providing new tools and solutions in clinical research to improve the quality of life for patients suffering from spine conditions."

Mr. Iftiniuk brings more than 25 years of experience in hospital management and healthcare consulting to SpineMark. He has been an industry leader in growing and restructuring both commercial and non-profit hospital- based entities to meet financial and quality of care objectives. In his role as interim chief operating officer of SpineMark Corporation, Mr. Iftiniuk will oversee SpineMark's Centers of Excellence and help to create institutions which are both fiscally responsible as well as leaders in innovative spine care. In addition to his role with SpineMark, Alan is currently the President and Chief Executive Officer of French Hospital Medical Center in San Louis Obispo, California, a Catholic Healthcare West (CHW) facility. In 1999, as CEO of Good Shepherd Hospital in Barrington Ill., Alan built a successful NeuroSpine Center of Excellence and Wellness center with SpineMark's support and guidance.

"Having been on the hospital side, I am looking forward to using that experience to help SpineMark's Centers of Excellence meet financial and quality of care objectives that will dramatically improve quality of care and patient satisfaction," commented Mr. Iftiniuk. "We are ultimately interested in bringing the best spine care to patients while also creating a sustainable business for our affiliate physicians and institutions."

About SpineMark

SpineMark Corporation, headquartered in San Diego, combines the clinical, business development, contracting, marketing and research expertise to establish Spine Centers of Excellence. Additionally, SpineMark's subsidiary, SpineMark CRO Management Inc., conducts national FDA trials at the Centers of Excellence. Formed as a joint venture between Texas Back Institute Holdings and Management Technology Resources, SpineMark is dedicated to unite all of the necessary experience and expertise under the management of recognized leaders in both the business and medical world of spine care. To learn more about SpineMark, visit:

SOURCE SpineMark Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. The Cleveland Clinic Expands Its Services across the World via the Net
2. Ranbaxy Expands By Acquiring A Generic Company In Belgium
3. Insulin and Growth Hormone, Expands Life Span?
4. Health Insurance Company Expands Product Range
5. Bird Flu Outbreak Expands in Vietnam
6. New Modality in Migraine Management
7. Self-Management Program Beneficial for Back Pain
8. Self-Management Program Beneficial for Back Pain
9. Disease Management Programs – Effective for Heart Patient
10. Effective Management Of Heart Patients
11. New advance in prostate cancer management
Post Your Comments:
(Date:11/27/2015)... ... 27, 2015 , ... The men and women on this ... in the country. They have overseen financial turnarounds, shown commitment to their community ... industry as a whole through their advocacy and professional efforts. , Becker's Hospital ...
(Date:11/27/2015)... ... November 27, 2015 , ... Indosoft Inc., developer ... incorporation of Asterisk 11 LTS (Long Term Support) into its Q-Suite 5.10 product ... Q-Suite 5.10 up-to-date with a version of Asterisk that will receive not only ...
(Date:11/26/2015)... Cambridge, ON (PRWEB) , ... November 26, 2015 ... ... availability of a real-time eReferral system for diagnostic imaging in the Waterloo region. ... mammography, BMD and Nuclear Medicine tests directly from their electronic medical record (EMR) ...
(Date:11/26/2015)... NE (PRWEB) , ... November 26, 2015 , ... Jobs ... searched by healthcare professionals and offered by healthcare staffing agency Aureus Medical Group ... during the month of October 2015 among those searching for healthcare jobs through the ...
(Date:11/26/2015)... ... November 26, 2015 , ... Pixel Film Studios ... titles with ProTrailer: Vintage. This newly styled ProTrailer pack comes with 30 all-new ... any font, giving users limitless opportunities to stylize and create designs quickly and ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 26, 2015 ... "Radioimmunoassay Market by Type (Reagents & ... Academics, Clinical Diagnostic Labs), Application (Research, Clinical ... 2020" report to their offering. ... addition of the "Radioimmunoassay Market by ...
(Date:11/25/2015)... ) ... "Global Brain Monitoring Devices Market 2015-2019" ... ) has announced the addition of ... 2015-2019" report to their offering. ... ) has announced the addition of the ...
(Date:11/25/2015)... 2015  Amgen (NASDAQ: AMGN ) today announced ... the United States (U.S.) Food ... candidate to Humira ® (adalimumab). Amgen believes this ... the FDA and represents Amgen,s first BLA submission using ... , M.D., executive vice president of Research and Development ...
Breaking Medicine Technology: